Tower Research Capital LLC (Trc) Homology Medicines, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.84 - $1.43 $266 - $453	317 New	317 $0
Q1 2023 May 09, 2023	SELL	$0.91 - $1.69 $14,151 - $26,281	-15,551 Reduced 86.69%	2,387 $2,000
Q4 2022 Feb 10, 2023	BUY	$1.09 - $2.04 $12,900 - $24,143	11,835 Added 193.92%	17,938 $23,000
Q3 2022 Nov 10, 2022	SELL	$1.55 - $3.01 $1,336 - $2,594	-862 Reduced 12.38%	6,103 $10,000
Q2 2022 Aug 15, 2022	BUY	$1.39 - $3.12 $5,105 - $11,459	3,673 Added 111.57%	6,965 $14,000
Q1 2022 May 12, 2022	SELL	$2.6 - $4.17 $60,421 - $96,906	-23,239 Reduced 87.59%	3,292 $10,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $92,506 - $197,720	25,414 Added 2275.2%	26,531 $96,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $13,456 - $19,501	-2,239 Reduced 66.72%	1,117 $8,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $138 - $221	23 Added 0.69%	3,356 $24,000
Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $2,686 - $4,336	-293 Reduced 8.08%	3,333 $32,000
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $213,696 - $318,388	-23,957 Reduced 86.85%	3,626 $41,000
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $176,713 - $294,937	17,778 Added 181.32%	27,583 $296,000
Q2 2020 Aug 13, 2020	BUY	$12.07 - $19.34 $118,346 - $189,628	9,805 New	9,805 $149,000
Q1 2020 May 15, 2020	SELL	$12.5 - $22.04 $41,500 - $73,172	-3,320 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$11.42 - $22.19 $30,400 - $59,069	2,662 Added 404.56%	3,320 $69,000
Q3 2019 Nov 05, 2019	BUY	$14.74 - $22.28 $9,698 - $14,660	658 New	658 $12,000
Q2 2019 Aug 13, 2019	SELL	$18.35 - $30.34 $8,954 - $14,805	-488 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$19.76 - $29.57 $9,642 - $14,430	488 New	488 $14,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account